Autologous Cellular Immunotherapy in Patients With Metastatic Bladder Urothelial Carcinoma
Clinical trial NCT03389438 · TERMINATED
Trial details
- NCT number
- NCT03389438
- Sponsor
- Beijing Huanxing Cancer Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-26
- Primary completion
- 2021-02-26
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.